Perrigo Announces Approval For Over The Counter Children’s Cetirizine Oral Solution

Posted by poster | Uncategorized | Monday 21 July 2008 2:35 pm

Perrigo Company
(Nasdaq: PRGO; TASE) announced that it has received final approval
from the U.S. Food and Drug Administration to manufacture and market
over-the-counter (OTC) Children’s Cetirizine Hydrochloride Oral Solution
(Allergy) and Children’s Cetirizine Hydrochloride Oral Solution
(Hives-Relief), 1mg/mL.
The product will be marketed under store brand labels and is comparable
to McNeil Consumer Healthcare’s Children’s Zyrtec(R) (more…)

St. Jude Medical Awarded U.S. Patent For Neurostimulation Therapy For Depression

Posted by poster | Uncategorized | Sunday 20 July 2008 1:35 pm

St. Jude Medical, Inc. (NYSE:STJ) announced it has been awarded a patent from the U.S. Patent and Trademark Office for treating depression using neurostimulation therapy in an area of the brain known as Brodmann Area 25.
Brodmann Area 25 is a structure within the subcollosal gyrus region of the brain. It is the focus of the St. Jude Medical BROADEN(TM) (BROdmann Area 25 DEep brain Neuromodulation) study, which is evaluating whether deep (more…)

Extending Life By Tackling Depression In Cancer Patients

Posted by poster | Uncategorized | Sunday 20 July 2008 1:35 pm

generic acomplia online buy A study recommended by David Spiegel of Faculty of 1000 Medicine (), looks at the relationship between depression care management and survival rates in older patients. He identifies it as "an important and well-conducted study (more…)

Pregnancy rates decrease and miscarriages increase when a father is over 35

Posted by poster | Uncategorized | Saturday 19 July 2008 12:35 pm

Men’s Health News
Pregnancy rates decrease and miscarriages increase when a father is over 35 years of age, a scientist will tell the 24th annual conference of the European Society of Human Reproduction and Embryology (Monday 7 July). Buy ultram pills Dr. Stephanie Belloc, of (more…)

New Powerful Antihypertensive MicardisPlus® 80/25 (80mg Telmisartan/25mg Hydrochlorothiazide) Approved By EU Commission

Posted by poster | Uncategorized | Saturday 19 July 2008 12:35 pm

Boehringer Ingelheim announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug MicardisPlus® 80/25 in all 27 EU member states. It will be launched in Germany and Denmark in the coming weeks, followed soon by Ireland, the United Kingdom and the rest (more…)

« Previous PageNext Page »